Tag: Medoxomil

According to prescribing information and medical reports, hair loss or thinning is a documented, though rare, side effect associated with olmesartan Medoxomil. This potential reaction is a concern for some patients, leading to questions about the frequency, cause, and management of this specific side effect.

First approved for medical use in 2002, olmesartan medoxomil is a widely prescribed angiotensin II receptor blocker used to manage high blood pressure. A key part of its function is the medoxomil moiety, a prodrug that is rapidly converted into the active compound, olmesartan, after ingestion, improving bioavailability and effectiveness.